A rational design strategy of the novel topoisomerase II inhibitors for the synthesis of the 4-O-(2-pyrazinecarboxylic)-4′-demethylepipodophyllotoxin with antitumor activity by diminishing the relaxation reaction of topoisomerase II-DNA decatenation |
| |
摘 要: |
|
收稿时间: | 30 January 2014 |
本文献已被 ScienceDirect 等数据库收录! |
|